Skip to content
Disclosery

ORBIMED ADVISORS LLC: TRVI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on TRVI, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,430,293 TRVI shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,430,293 shares
    Change vs previous 13F -1,024,107 shares

    0.51% of the 13F portfolio, value $26,674,964.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,454,400 shares
    Change vs previous 13F -736,300 shares

    0.64% of the 13F portfolio, value $29,280,992.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,190,700 shares
    Change vs previous 13F -117,700 shares

    0.82% of the 13F portfolio, value $39,947,564.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,308,400 shares
    Change vs previous 13F 0 shares

    0.73% of the 13F portfolio, value $30,271,860.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,308,400 shares
    Change vs previous 13F +2,188,400 shares

    0.46% of the 13F portfolio, value $18,096,948.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,120,000 shares
    Change vs previous 13F not available

    0.17% of the 13F portfolio, value $7,044,800.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).